TempraMed Technologies
Tracked across 2 events · 12 articles · First seen Sep 01, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: TempraMed is the primary party, signing the LOI to expand into Greece. This supports its international growth strategy and could lead to increased sales, but the non-binding nature and pending definitive agreement temper immediate benefits.
Sep 01, 2026 · 6 articles
Business
TempraMed Technologies, a Canadian medical-device company trading on the CSE under VIVI, announced it entered into a distribution agreement dated August 25, 2026 with CenterWell Pharmacy, the pharmacy services brand of U.S. health insurer Humana…
Impact: TempraMed is the primary beneficiary of the distribution agreement, gaining access to CenterWell Pharmacy's U.S. distribution channel for its VIVI Cap and VIVI Epi products. The deal could support revenue growth, but the lack of minimum purchase commitments and easy termination keep the benefit uncertain.
Sep 23, 2026 · 6 articles
90
TempraMed Technologies entered distribution agreement CenterWell PharmacyTempraMed CenterWell...
ERGEN INTELLIGENCE
Track TempraMed Technologies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard